Table 2.
Drug and concentration | IC50 (μM) | Resistance times | Reversing times | |
---|---|---|---|---|
K562 | K562/ADR | |||
ADR | 0.45 ± 0.11 | 13.97 ± 0.30* | 31.04 | |
ADR + CH (5 μM) |
0.44 ± 0.12 | 1.62 ± 0.10∗△ | 3.68 | 8.43 |
ADR + VER (5 μM) |
0.46 ± 0.07 | 6.07 ± 0.18∗△☆ | 13.19 | 2.35 |
Cells were exposed to various concentrations of ADR, with or without 5 μM CH, or VER for 48 h. ∗P < 0.05 compared with K562 treated with ADR, or ADR cotreated with CH or VER, △ P < 0.05 compared with K562/ADR treated with ADR, ☆ P < 0.05 compared with K562/ADR treated with ADR plus CH.